Anakinra biosimilar(University of Pennsylvania)

阿那白滞素生物类似药（University of Pennsylvania）

Report date: 2024/02/07 17:07:29

Base Information

Drug NameAnakinra biosimilar(University of Pennsylvania)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsLeishmaniasis, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsLeishmaniasis, Cutaneous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A